Stock News

Washington Health Care Facilities Auth -- Moody's upgrades Fred Hutchinson Cancer Research Center (WA) to A2 from A3; outlook stable
U.S. court rejects Alvogen's patent challenge for Celgene's cancer drug
U.S. patent court rejects Alvogen's challenge for Celgene's Revlimid
5 Biotech Stocks to Keep an Eye on in 2019

As seen on...